Ocular hypotensive efficacy of a new liposomal latanoprost formulation administered by different routes for experimental ocular hypertension. Ukr. j. ophthalmol. [Internet]. 2025 Aug. 27 [cited 2026 Aug. 9];(2):37-41. Available from: https://ua.ozhurnal.com/index.php/files/article/view/374